Dr. Lieberman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3471 Fifth Avenue
Pittsburgh, PA 15213Phone+1 412-641-1000Fax+1 412-641-1221- Is this information wrong?
Education & Training
- University of ChicagoNeuroimmunology, 1983 - 1985
- University of ChicagoResidency, Neurology, 1980 - 1983
- University of ChicagoInternship, Internal Medicine, 1979 - 1980
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1979
Certifications & Licensure
- PA State Medical License 1999 - 2024
- NJ State Medical License 1985 - 1991
- IL State Medical License 1980 - 1987
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors Start of enrollment: 2001 Oct 09
- Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2004 Nov 01
- Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas Start of enrollment: 2006 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 247 citationsDifferential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase InhibitorsIgor Vivanco, H. Ian Robins, Daniel Rohle, Carl Campos, Christian Grommes
Cancer Discovery. 2012-05-01 - 1361 citationsEffect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical TrialRoger Stupp, Sophie Taillibert, Andrew A. Kanner, William L. Read, David M. Steinberg
JAMA. 2017-12-19 - 810 citationsMaintenance therapy with tumor-Treating fields plus temozolomide vs temozolomide alone for glioblastoma a randomized clinical trialRoger Stupp, S. Taillibert, Andrew A. Kanner, Santosh Kesari, David M. Steinberg
JAMA. 2015-12-15
Press Mentions
- Comprehensive Genetic Profiling Possible for Central Nervous System TumorsFebruary 11th, 2016
- Test Rapidly, Accurately Profiles Genetics and Treatment of Brain TumorsFebruary 1st, 2016
Grant Support
- Nabtc Member Institution Grant (Ucsf Project Leader)National Cancer Institute2002–2008
- Phi/Ii Trial Of R115777 In PTS W/Recurrent Malignant GliomaNational Center For Research Resources2005
- PH II TRL Of EMD 121974 Rcurrent Glioblastoma Clin Trial W/Tissue Correlate RESPNational Center For Research Resources2005
- PH I/II Trial OSI-774 PTS W/Recurr Malig Gliomas &Malig Gliomas Post RadiatnNational Center For Research Resources2005
- Phi/Ii ZD1839 In Subj W/Recurr. Malig. Glioma MeningiomasNational Center For Research Resources2004
- Phi/Ii Trial Cpt-11/Temozolomide In Malignant GliomaNational Center For Research Resources2004
- PH I/II Trial OSI-774 PTS W/Recurr. Malig. GliomasNational Center For Research Resources2004
- Gene Therapy For Recurrent Glioblastoma Multiforme--Phase I TrialNational Center For Research Resources1998–2002
Professional Memberships
- Member
Hospital Affiliations
- UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
- UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
- Shadyside CampusPittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: